Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Isupova EA, Kuchinskaya EM, Glebova NI, Buchinskaya NV, Kalashnikova OV, Chasnyk VG. Kostik MM, et al. Among authors: chikova ia. Pediatr Rheumatol Online J. 2015 Jan 23;13:4. doi: 10.1186/1546-0096-13-4. eCollection 2015. Pediatr Rheumatol Online J. 2015. PMID: 25685108 Free PMC article.
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Likhacheva TS, Isupova EA, Glebova NI, Kuchinskaya EM, Balbotkina EV, Buchinskaya NV, Kalashnikova OV, Chasnyk VG. Kostik MM, et al. Among authors: chikova ia. Semin Arthritis Rheum. 2015 Feb;44(4):417-22. doi: 10.1016/j.semarthrit.2014.09.004. Epub 2014 Sep 11. Semin Arthritis Rheum. 2015. PMID: 25300700
Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VV, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG. Kostik MM, et al. Among authors: chikova ia. Clin Exp Rheumatol. 2016 Jul-Aug;34(4):714-8. Epub 2016 Jun 22. Clin Exp Rheumatol. 2016. PMID: 27385618
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis.
Tibaldi J, Pistorio A, Aldera E, Puzone L, El Miedany Y, Pal P, Giri PP, De H, Khubchandani R, Chavan PP, Vilaiyuk S, Lerkvaleekul B, Yamsuwan J, Sabui TK, Datta P, Pardeo M, Bracaglia C, Sawhney S, Mittal S, Hassan WA, Elderiny GF, Abu-Zaid MH, Eissa M, Sztajnbok F, das Neves Sztajnbok FC, Russo R, Katsicas MM, Cimaz R, Marrani E, Alexeeva E, Dvoryakovskaya TM, Alsuweiti MO, Alzyoud RM, Kostik M, Chikova I, Minoia F, Filocamo G, Farag Y, Lotfy H, Nasef SI, Al-Mayouf SM, Maggio MC, Magalhaes CS, Gallizzi R, Conti G, Shimizu M, Civino A, Felici E, Giancane G, Ruperto N, Consolaro A, Ravelli A. Tibaldi J, et al. Rheumatology (Oxford). 2020 Nov 1;59(11):3505-3514. doi: 10.1093/rheumatology/keaa240. Rheumatology (Oxford). 2020. PMID: 32829413
Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics.
Kostik MM, Gaidar EV, Sorokina LS, Avrusin IS, Nikitina TN, Isupova EA, Chikova IA, Korin YY, Orlova ED, Snegireva LS, Masalova VV, Dubko MF, Kalashnikova OV, Chasnyk VG. Kostik MM, et al. Among authors: chikova ia. Front Pediatr. 2022 Jun 15;10:849940. doi: 10.3389/fped.2022.849940. eCollection 2022. Front Pediatr. 2022. PMID: 35783325 Free PMC article.
Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.
Kostik MM, Isupova EA, Belozerov K, Likhacheva TS, Suspitsin EN, Raupov R, Masalova VV, Chikova IA, Dubko MF, Kalashnikova OV, Chasnyk VG, Cron RQ. Kostik MM, et al. Among authors: chikova ia. Front Pediatr. 2022 Jul 28;10:894846. doi: 10.3389/fped.2022.894846. eCollection 2022. Front Pediatr. 2022. PMID: 35967555 Free PMC article.
Case report: Sulfasalazine-induced hypersensitivity.
Kuchinskaya EM, Chikova IA, Kostik MM. Kuchinskaya EM, et al. Among authors: chikova ia. Front Med (Lausanne). 2023 May 24;10:1140339. doi: 10.3389/fmed.2023.1140339. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37293296 Free PMC article.